Endocrinology Associates Inc, Columbus, OH, USA.
Case Western Reserve University School of Medicine, Cleveland, OH, USA.
J Prim Care Community Health. 2021 Jan-Dec;12:21501327211003683. doi: 10.1177/21501327211003683.
Chronic kidney disease (CKD) in patients with type 2 diabetes (T2D) is associated with increased risk of end-stage renal disease (ESRD) and cardiovascular disease (CVD). Urine albumin-to-creatinine ratio (UACR) is a sensitive and early indicator of kidney damage, which should be used routinely to accurately assess CKD stage and monitor kidney health. However, this test currently is performed in only a minority of patients with T2D. Here, we review the importance of albuminuria testing and current barriers that hinder patient access to UACR testing and describe solutions to such testing in a community clinical setting.
2 型糖尿病（T2D）患者的慢性肾脏病（CKD）与终末期肾病（ESRD）和心血管疾病（CVD）的风险增加有关。尿白蛋白与肌酐比值（UACR）是肾脏损伤的敏感和早期指标，应常规用于准确评估 CKD 分期和监测肾脏健康。然而，目前只有少数 T2D 患者进行了这项检查。在这里，我们回顾了蛋白尿检测的重要性以及目前阻碍患者接受 UACR 检测的障碍，并描述了在社区临床环境中解决此类检测的方法。
